Dr. Brawer on the Results of the Prolaris Test for Patients Prostate Cancer

Michael Brawer, MD
Published: Tuesday, Sep 05, 2017



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the results of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

It has been known for a long time that African-American men not only have more prostate cancer, but also have worse prostate cancer for reasons that are still unknown, states Brawer.

Ongoing studies are attempting to determine if there are biological differences that cause this increase in cancer, explains Brawer.



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the results of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

It has been known for a long time that African-American men not only have more prostate cancer, but also have worse prostate cancer for reasons that are still unknown, states Brawer.

Ongoing studies are attempting to determine if there are biological differences that cause this increase in cancer, explains Brawer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x